Clinical trial
Investigation of Genetic Variations on Patients With Adverse Events While on Direct Oral Anticoagulants (DOACs)
NCT04580589 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Genetic Variations on Patients With Adverse Events While on Direct Oral Anticoagulants (DOACs)
- Lead sponsor
- Cipherome, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2021
- Completion date
- October 31, 2022
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-related side effects and adverse reactions, treatment failure